Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
23%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
CANC
50
HOLDINGS
22%
ALSO IN IDNA
IDNA
44
HOLDINGS
29%
ALSO IN CANC
SECTOR DRIFT (CANC minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in CANC |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
ASTRAZENECA PLC | 4.4% | 4.3% | 4.3% | |
REVOLUTION MEDICINES, INC. | 5.3% | 3.5% | 3.5% | |
ARCELLX, INC. | 3.1% | 4.1% | 3.1% | |
EXELIXIS INC | 3.1% | 3.5% | 3.1% | |
MERCK & CO. INC. | 2.3% | 4.3% | 2.3% |
CANC Overweight Relative to IDNA
BRIDGEBIO PHARMA, INC. | 5.1% | |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% | |
NOVARTIS AG | 4.6% | |
MERUS N.V. | 4.4% | |
GENMAB A/S SPONSORED ADR | 4.1% | |
ELI LILLY & CO | 3.8% | |
BEIGENE LTD. SPONSORED ADR | 3.1% | |
NUVALENT, INC. CLASS A | 3.1% | |
SUMMIT THERAPEUTICS INC | 3.1% | |
BRISTOL-MYERS SQUIBB CO | 3.1% |
CANC Underweight Relative to IDNA
INCYTE CORP | -4.8% | |
GENMAB A/S | -4.3% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.1% | |
BIONTECH SE SPONSORED ADR | -4.0% | |
SANOFI-AVENTIS | -4.0% | |
ROCHE HOLDING LTD | -3.9% | |
MODERNA, INC. | -3.8% | |
GSK PLC | -3.8% | |
TWIST BIOSCIENCE CORP. | -3.5% | |
REGENERON PHARMACEUTICALS | -3.2% |